National patterns of dementia treatment among elderly ambulatory patients

Journal of the National Medical Association

Volumn 98, Issue 3, 2006, Pages 430-435

  Maneno, Mary K ^a   Lee, Euni ^a   Wutoh, Anthony K ^a   Zuckerman, Ilene H ^b   Jackson, Patrice ^a   Lombardo, Fredric A ^a   Scott, Kenneth R ^a   Xue, Zhenyi ^a  

^a HOWARD UNIVERSITY   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

Author keywords

Alzheimer's disease; Ambulatory care; Cholinesterase inhibitors; Dementia; Elderly

Indexed keywords

CHOLINESTERASE INHIBITOR; DONEPEZIL; GALANTAMINE; RIVASTIGMINE;

ADULT; AGED; AMBULATORY CARE; COGNITION; CONSULTATION; DEMENTIA; ELDERLY CARE; EVALUATION; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MEDICAL SPECIALIST; PREDICTION; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; REVIEW;

AGED; AMBULATORY CARE; CHOLINESTERASE INHIBITORS; DEMENTIA; FEMALE; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTIONS, DRUG; UNITED STATES;

EID: 33644793610     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Mega MS, Cummings JL, Fiorello T, et al. The spectrum of behavioral changes in Alzheimer's disease. Neurology. 1996;46:130-135.
2. Finkel S. Behavioral disturbance in dementia. Int Psychogeriatr. 1996;8 (Suppl 3):215-551.
3. Drevets WC, Rubin EH. Psychotic symptoms and the longitudinal course of Alzheimer's disease. Biol Psychiatry. 1989;25:39-48.
4. Seshadri S, Wolf PA, Beiser A, et al. Lifetime risk of dementia and Alzheimer's disease: the impact of mortality on risk estimates in the Framingham study. Neurology. 1997;49:1498-1504.
5. Gao S, Hendrie HC, Hall KS, et al. The relationships between age, sex and incidence of dementia and Alzheimer's disease: a meta-analysis. Arch Gen Psychiatry. 1998;55:809-815.
6. Crismon ML, Eggert AE. Alzheimer's disease. In: Pharmacist Care Mental Health, Institute for Pharmacist Care Outcomes, 2000:ALZ1-ALZ29.
7. Hendrie HC. Epidemiology of dementia and Alzheimer's disease. Am J Geriatr Psychiatry. 1998:6(2 Suppl 1):S3-S18.
8. Bachman DL, Wolf PA, Knoefel JE, et al. Prevalence of dementia and probable senile dementia of the Alzheimer's type in the Framingham study. Neurology. 1992;42:115-119.
9. Husaini BA, Sherkat DE, Mooniz M, et al. Racial differences in the diagnosis of dementia and its effects on the use and costs of health care services. Psychiatr Serv. 2003;54:92-96.
10. Callahan CM, Hendrie HC, Tierney WM. Documentation and evaluation of cognitive impairment in elderly primary care patients. Ann Intern Med. 1995;122(6):422-429.
11. Doraiswamy PM. Early recognition of Alzheimer's disease: What is consensual? What is controversial? What is Practical? J Clin Psychiatry. 1998;59(Suppl 13):6-18.
12. Doody R, Geldmacher D, Gordon B, et al. Open-label, multicenter, phase III extension study of the safety and efficacy of donepezil in patients with Alzheimer's disease. Arch Neurol. 2001;58(3):427-433.
13. Perkins P, Annegers JF, Doody RS, et al. Incidence and prevalence of dementia in multiethnic cohort of municipal retirees. Neurology. 1997;49:44-50.
14. Folstein MF, Basset SS, Anthony JC, et al. Dementia: case ascertainment in a community dwelling survey. J Gerontol. 1991;46:M132-M138.
15. Gurland BJ, Wilder DE, Lantigua R. Rates of dementia in three ethnoracial groups. Int J Geriatr Psychiatry. 1999;14:481-493.
16. Heyman A, Fillembaum G, Prosnitz B, et al. Estimated prevalence of dementia among elderly black and white community residents. Arch Neurol. 1991;48:594-598.
17. Shadlen MF, Larson EB, Gibbons L, et al. Alzheimer's disease symptom severity in blacks and whites. J Am Geriatr Soc. 1999;47:482-486.
18. Weintraub D, Raskin A, Ruskin PE. Racial differences in the prevalence of dementia among patients admitted to nursing homes. Psychiatr Serv. 2000;51:1259-1264.
19. Rabins PV. Guideline watch. Practice guideline for the treatment of patients with Alzheimer's disease and other dementias of late life. Arlington, VA: American Psychiatric Association. www.psych.org/psych_pract/treatg/pg/ prac_guide.dfm. Accessed 06/18/05.
20. Guo Z, Vittanen M, Winbald B, et al. Low blood pressure and incidence of dementia in a very old sample: dependent on initial cognition. J Am Geriatr Soc. 1999;47:723-726.
21. Baker FM. Dementing illnesses in African American populations: evaluation and management for the primary physician. J Geriatr Psychiatry. 1991;24:73-91.
22. Baker FM. Ethnic minority elders: a mental health research agenda. Hosp Community Psychiatry. 1992;43:337-338.
23. Baker FM. Psychiatric treatment of older African Americans. Hosp Community Psychiatry. 1994;45:32-37.
24. Myers JS, Rauch GM, Rauch RA, et al. Cardiovascular and other risk factors for Alzheimer's disease and vascular dementia. Ann N Y Acad Sci. 2000;903:411-423.
25. Skoog I. Status of risk factors for vascular dementia. Neuroepidemiology. 1998;17:2-9.
26. Rosler M, Anand R, Cicin-Sain A, et al. Efficacy and safety of rivastigmine in patients with Alzheimer's disease: International randomized controlled trial. Br Med J. 1999;318(7184):633-638.
27. Griffith VT. Diagnose and treat mild to moderate Alzheimer's disease. Nurse Pract. 2002;27(12):13-25.
28. Rabins PV. Practice guidelines for the treatment of patients with Alzheimer's disease and other dementias of late life. Am J Psychiatr. 1997;154(suppl 5):1-39.
29. Small GW, Rabins PV, Barry PP, et al. Diagnosis and treatment of Alzheimer's disease and related disorders: Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association and the American Geriatrics Society. JAMA. 1997;278:1363-1371.
30. Cherry DK, Burt CW, Woodwell DA. National Ambulatory Medical Care Survey. 1999 Summary. Advance data from vital and health statistics; No. 322. Hyattsville, MD: National Center for Health Statistics; 2001.
31. U.S. Department of Health and Human Services and the Centers for Disease Control and Prevention. NAMCS description Web page, 2002. www.cdc.gov/nchs/ about/major/ahcd/namc-sdes.htm. Accessed 04/12/05.
32. Cherry DK, Woodwell DA. National Ambulatory Medical Care Survey: 2000 Summary. Advance data from vital and health statistics; No. 328. Hyattsville, MD: National Center for Health Statistics; 2002.
33. Susan LK, Robins LN, Earls F. Treatment seeking for depression by black and white Americans. Soc Sci Med. 1987;24:187-196.
34. Hough RL, Landsverk JA, Karno M, et al. Utilization of health and mental health services by Los Angeles Mexican Americans and non-Hispanic whites. Arch Gen Psychiatry. 1987;44(8):702-709.
35. Olfson M, Klerman GL. The treatment of depression: prescribing practice of primary care physicians and psychiatrists. J Fam Pract. 1992;35:627-635.
36. Olfson M, Pincus HA. Outpatient Psychotherapy in the United States, I; volume, costs and user characteristics. Am J Psychiatry. 1994;151:1281-1287.
37. Lasser KE, Himmelstein DU, Woolhandler SJ, et al. Do minorities receive fewer mental health services than whites? Int J Health Serv. 2002;32(3):567-578.
38. Weintraub D, Raskin A, Ruskin PE. Racial differences in the prevalence of dementia among patients admitted to nursing homes. Psychiatr Serv. 2000;51:1259-1264.
39. Rabins, PV. Guideline watch: Practice guideline for the treatment of patients with Alzheimer's disease and other dementias of late life. American Psychiatric Association; 2004. www.psych.org/psych_pract/treatg/pg/prac_guide. cfm. Accessed 06/02/05.
40. Richards S, Hendries H. Diagnosis, Management and Treatment of Alzheimer's Disease: A Guide for the Internist. Ann Intern Med. 1999;159(8): 789-798.
41. Petersen RC, Stevens JC, Ganguli M, et al. Practice parameter; early detection of dementia: mild cognitive impairment (an evidence-based review). Neurology. 2001;56:1133-1142.